As of 28 Aug 2026, Medicamen Biotech Ltd share price is ₹229.60. The stock opened at ₹229.60 and had closed at ₹240.30 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹210.10 and a high of ₹454.00. In terms of performance, Medicamen Biotech Ltd share price has decreased by 21.45% over the past six months and has decreased by 33.28% over the last year.
MEDICAMEQ Charts
Medicamen Biotech Ltd Overview
About MEDICAMEQ
Medicamen Biotech is engaged in Generic Finished Dosage Forms, Oncology Formulations and Research & Development services to cater to the needs of the Global Pharmaceuticals Industry.
Medicamen Biotech Ltd Historical Performance
Medicamen Biotech Ltd Fundamental Analysis
Medicamen Biotech Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 44.71 | 56.41 | 44.02 | 42.60 | 38.92 |
| EBITDA | 5.64 | 5.86 | 5.61 | 5.42 | 4.50 |
| Net Profit | 2.53 | 2.97 | 2.59 | 2.21 | 1.64 |
| EPS | 1.86 | 2.19 | 1.91 | 1.63 | 1.21 |
Medicamen Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 51.16 |
| MACD | -0.86 |
| 20-Day SMA | 237.68 |
Medicamen Biotech Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Medicamen Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Medicamen Biotech Ltd today is ₹229.60 on NSE and ₹229.60 on BSE.
- The 52-week high of Medicamen Biotech Ltd is ₹454.00, while the 52-week low is ₹210.10.
- The current market capitalisation of Medicamen Biotech Ltd is approximately ₹311 crore.
- The P/E (Price-to-Earnings) ratio of Medicamen Biotech Ltd is 57.06. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Medicamen Biotech Ltd is 1.49. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Medicamen Biotech Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Medicamen Biotech Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Medicamen Biotech Ltd has delivered a return of approximately -66.77%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Medicamen Biotech Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 40.46% promoters, 0.07% FIIs, 0.40% DIIs, and 32.10% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
